Drug class of 2015 heavy on blockbusters; Isis touts more early data;

@FierceBiotech: In a squeaker, FierceBiotech readers warn of a biotech bubble. Editor's corner | Follow @FierceBiotech

@JohnCFierce: Is it important that Biogen dropped Idec? No. Will everyone comment on it? Yes. News is funny that way. More | Follow @JohnCFierce

@DamianFierce: Auxogyn is a really good name for an IVF company, imo. FierceMedicalDevices story | Follow @DamianFierce

> 2015 is shaping up to be a year full of blockbuster drug launches, Reuters says. Story

> Regeneron ($REGN) is trimming the benefits of its two top executives, axing, among other amenities, CEO Len Schleifer's $18,500 golf course membership in an effort to simplify its compensation structure. More

> Isis ($ISIS) touted more positive results for an early-stage antisense drug, ISIS-ANGPTL3 for high triglycerides, but didn't disclose how the drug performed against placebo. Item

Medical Device News

@FierceMedDev: ICYMI: Sebacia reveals positive data for acne-fighting gold microparticle device. Article | Follow @FierceMedDev

@VarunSaxena2: DOJ cracks down on devicemakers in 2014 with $100M+ in fines. Editor's corner | Follow @VarunSaxena2

@EmilyWFierce: Highlight of my Monday: Foundation Medicine's new president and COO is named Kafka. Release | Follow @EmilyWFierce

> Edwards-backed CardioKinetix reports China heart failure data, US pivotal results expected in 2016. Article

> ReWalk Robotics stumbles 6 months after IPO. Story

Pharma News

@FiercePharma: Japan's Riken plans trial on transplanting stem cells of unrelated donors. FiercePharmaAsia article | Follow @FiercePharma

@EricPFierce: India's Micro Labs, whose Bangalore plant was banned by FDA, is recalling simvastatin made at Goa facility. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: We're back with #FierceMadness Round 3 today. Did you miss us? More at FiercePharmaMarketing | Follow @CarlyHFierce

> Gilead warns of fatal reaction to Sovaldi, Harvoni and heart drug. More

> AbbVie CEO pads $16M paycheck with $500K in jet travel. News

Animal Health News

> Integrated Animal Health forms 10-year research pact with NMSU on herd health. More

> 3D Systems preps for global launch of 'printed' knee implants for dogs. Article

> Researchers examine role of dog ownership on beneficial bacteria. Item

> VCA division Antech buys Abaxis vet-lab assets for $21M. News

> Wild birds to blame for avian flu outbreak? Not so fast, say scientists. Story

Biotech IT News

> Cloud Pharmaceuticals allies with U. of Florida to advance in silico pipeline. News

> FDA under pressure to establish staff social media policy. More

> Big Pharma nervously eying Apple and Google's healthcare pitches. Item

> India crowdsources whistleblowing with website, mobile app. Story

> AstraZeneca taps Assay Depot to create preclinical service hub. Report

Suggested Articles

When thinking about clinical research patient recruitment, a crucial step is building effective patient recruitment advertising campaigns.

Novavax delayed the start of a large phase 3 trial for its COVID-19 vaccine in the U.S. and Mexico, thanks to delays in scaling up manufacturing.

The decision to dump IL33r antagonist GSK3772847 follows lackluster clinical data on rival candidates against the same target.